Data / Form D filings / OrsoBio, Inc.
OrsoBio, Inc.: Form D filings
OrsoBio, Inc., a biotechnology company in Menlo Park, CA, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on August 28, 2024, reports $40 million sold of a $67 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 JEFFERSON DR 1ST FLOOR STE 124, Menlo Park, CA, 94025
- Phone
- (650) 208-8348
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2000354
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | New notice | $67,000,000 | $40,000,000 | $27,000,000 | 7 | Aug 14, 2024 | sec.gov |
| Nov 13, 2023 | New notice | $84,629,383 | $84,629,383 | 6 | Oct 27, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Matthew Young | Director | |
| Mani Subramanian | Executive Officer, Director | |
| Srinivas Akkaraju | Director | |
| Cory Freedland | Director | |
| Edward Fleming | Director | |
| Evan Rachlin | Director | |
| Muzammil Mansuri | Director | |
| Gangadhara Ganapati | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Aug 26, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OrsoBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.